Dermatol. praxi. 2008;2(3):134-138

Dysplastic nevus, dysplastic nevi syndrome and other melanocytic pigmented nevi

MUDr. Miloslav Salavec CSc, MUDr. Jarmila Čelakovská, MUDr. Marie Šimková
Klinika nemocí kožních a pohlavních, LF UK a FN v Hradci Králové

Paper reviews pigmented melanocytic lesions of the skin. Classification, clinical and histological features of individual melanocytic lesions are described. Furthermore knowledge on melanocytic tumor progression from dysplastic nevi is reviewed.

Keywords: melanocytic nevi, dysplastic nevi, dysplastic nevi syndrome, common melanocytic nevi (junctional, compound), blue nevus, dermal melanocytic nevi, Spitz nevus, Halo nevus, congenital melanocytic nevus, special forms of dermal melanocytic nevi

Published: December 20, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Salavec M, Čelakovská J, Šimková M. Dysplastic nevus, dysplastic nevi syndrome and other melanocytic pigmented nevi. Dermatol. praxi. 2008;2(3):134-138.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bale SJ, Dracopoli NC, Tucker MA et al. Mapping the gene for hereditary cutaneous malignant melanoma - dysplastic nevus to chromosome 1p. N Engl J Med, 1998; 28(324): 925.
    2. Braun-Falco O, Plewig G, Wolff HH. Dermatológia a venerológia. Nakladatelství Osveta, 2001: 1146-1155. Go to original source...
    3. Burkhart CG. Dysplastic Nevus Declassified: Even the NIH Recommends Elimination of Confusing Terminology. Skinmed 2003; 2(1): 12-13. Go to original source... Go to PubMed...
    4. Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions., ,The B-K Mole Syndrome". Arch Dermatol 1978; 114: 732-738. Go to original source... Go to PubMed...
    5. Foulkes WD, Flanders TY, Polock PM, Hayward NK. The CDKN2a (p16) gene and human cancer. Mol Med, 1997; 3: 5-20. Go to original source...
    6. Herlyn M, Herlyn D, Elder DE et al. Phenotypic characteristics of cells derived from precursors of human melanoma. Cancer Res 1983; 43: 5502-5508.
    7. Hussein MRA, Wood GS. Molecular Aspects of Melanocytic Dysplastic Nevi. JMD 2002; 4(2): 71-80. Go to original source... Go to PubMed...
    8. Lynch HT, Fusaro RM, Pester J, Oosterhuis JA, Went LN, Rumke P, Neering H, Lynch JF. Tumour spectrum in the FAMMM syndrome. Br J Cancer 1981; 44: 553-560. Go to original source... Go to PubMed...
    9. Marghoob AA, Blum R, Nossa R et al. Agminated atypical (dysplastic) nevi. Arch Dermatol 2001; 137: 917-920. Go to PubMed...
    10. Pizinger K. Kožní pigmentové projevy. Grada publishing, 2003: 47.
    11. Rudolph P, Schubert C, Tamm S et al. Telomerase activity in melanocytic lesions - a potential marker of tumor biology. Am. J. Pathol. 2000; 156: 1425-1437. Go to original source... Go to PubMed...
    12. Rudolph P. Der Dysplastische Nävus. Pathologe 2002; 23: 128-134. Go to original source... Go to PubMed...
    13. Tousling S, Kamino H. Dysplastic changes in different types of melanocytic nevi. A unifying concept. J Cutan Pathol 1999; 26: 84-90. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.